Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1622 | 7034 | 32.9 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
613 | 3 | GOUT//HYPERURICEMIA//URIC ACID | 14056 |
1622 | 2 | GOUT//HYPERURICEMIA//URIC ACID | 7034 |
1775 | 1 | GOUT//FEBUXOSTAT//HYPERURICEMIA | 2492 |
2613 | 1 | URIC ACID//HYPERURICEMIA//SERUM URIC ACID | 2195 |
13862 | 1 | ALDEHYDE OXIDASE//XANTHINE DEHYDROGENASE//XANTHINE OXIDOREDUCTASE | 808 |
19227 | 1 | TUMOR LYSIS SYNDROME//RASBURICASE//TUMOUR LYSIS SYNDROME | 515 |
23511 | 1 | URICASE//UNIT ANALYT PROBES PROT BIOTECHNOLEDUC MINIST//URATE OXIDASE | 343 |
23780 | 1 | XANTHINE OXIDASE INHIBITOR//XANTHINE OXIDASE//XANTHINE OXIDASE INHIBITION | 335 |
27400 | 1 | RENAL HYPOURICEMIA//HYPOURICEMIA//EXERCISE INDUCED ACUTE RENAL FAILURE | 230 |
34074 | 1 | ALLANTOIN//ECHINOISOFLAVANONE//SOPHORA CHRYSOPHYLLA SEEM | 116 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GOUT | authKW | 3138733 | 15% | 68% | 1060 |
2 | HYPERURICEMIA | authKW | 2207573 | 10% | 73% | 696 |
3 | URIC ACID | authKW | 1634039 | 16% | 33% | 1154 |
4 | SERUM URIC ACID | authKW | 649029 | 3% | 78% | 193 |
5 | FEBUXOSTAT | authKW | 567418 | 2% | 85% | 153 |
6 | TUMOR LYSIS SYNDROME | authKW | 533710 | 2% | 74% | 166 |
7 | ALLOPURINOL | authKW | 470822 | 5% | 33% | 333 |
8 | RASBURICASE | authKW | 389455 | 1% | 92% | 98 |
9 | XANTHINE OXIDASE | authKW | 273884 | 4% | 21% | 303 |
10 | HYPERURICAEMIA | authKW | 266855 | 1% | 74% | 83 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 63440 | 17% | 1% | 1224 |
2 | Urology & Nephrology | 3841 | 7% | 0% | 527 |
3 | Medicine, General & Internal | 3614 | 12% | 0% | 837 |
4 | Peripheral Vascular Diseases | 1605 | 5% | 0% | 363 |
5 | Pharmacology & Pharmacy | 1536 | 11% | 0% | 781 |
6 | Endocrinology & Metabolism | 798 | 5% | 0% | 377 |
7 | Cardiac & Cardiovascular System | 780 | 5% | 0% | 383 |
8 | Integrative & Complementary Medicine | 446 | 1% | 0% | 78 |
9 | Chemistry, Medicinal | 445 | 3% | 0% | 221 |
10 | Medical Laboratory Technology | 380 | 1% | 0% | 104 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTEGRAT PHYSIOL BIONANO MED | 57881 | 0% | 43% | 31 |
2 | RHEUMATOL | 30632 | 8% | 1% | 538 |
3 | BIOMED ANALYT SCI | 25099 | 0% | 64% | 9 |
4 | HUMAN PHYSIOL PATHOL | 23621 | 0% | 78% | 7 |
5 | NEPHROL HYPERTENS TRANSPLANTAT | 22852 | 0% | 15% | 35 |
6 | KIDNEY HYPERTENS | 22335 | 0% | 18% | 28 |
7 | IWO TO AIR BASE GRP | 21696 | 0% | 100% | 5 |
8 | UNIT ANALYT PROBES PROT BIOTECHNOLEDUC MINIST | 21696 | 0% | 100% | 5 |
9 | SHANDONG PROV METAB DIS | 18880 | 0% | 31% | 14 |
10 | CLIN GOUT | 17357 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 15093 | 1% | 5% | 72 |
2 | JOURNAL OF RHEUMATOLOGY | 10772 | 3% | 1% | 180 |
3 | ANNALS OF THE RHEUMATIC DISEASES | 10186 | 2% | 2% | 146 |
4 | CURRENT OPINION IN RHEUMATOLOGY | 7885 | 1% | 3% | 53 |
5 | RHEUMATOLOGY | 6863 | 1% | 2% | 87 |
6 | ARTHRITIS CARE & RESEARCH | 5945 | 1% | 3% | 49 |
7 | CURRENT RHEUMATOLOGY REPORTS | 5735 | 0% | 5% | 25 |
8 | ARTHRITIS RESEARCH & THERAPY | 5170 | 1% | 2% | 63 |
9 | CLINICAL RHEUMATOLOGY | 4696 | 1% | 1% | 77 |
10 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 3582 | 1% | 1% | 63 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GOUT | 3138733 | 15% | 68% | 1060 | Search GOUT | Search GOUT |
2 | HYPERURICEMIA | 2207573 | 10% | 73% | 696 | Search HYPERURICEMIA | Search HYPERURICEMIA |
3 | URIC ACID | 1634039 | 16% | 33% | 1154 | Search URIC+ACID | Search URIC+ACID |
4 | SERUM URIC ACID | 649029 | 3% | 78% | 193 | Search SERUM+URIC+ACID | Search SERUM+URIC+ACID |
5 | FEBUXOSTAT | 567418 | 2% | 85% | 153 | Search FEBUXOSTAT | Search FEBUXOSTAT |
6 | TUMOR LYSIS SYNDROME | 533710 | 2% | 74% | 166 | Search TUMOR+LYSIS+SYNDROME | Search TUMOR+LYSIS+SYNDROME |
7 | ALLOPURINOL | 470822 | 5% | 33% | 333 | Search ALLOPURINOL | Search ALLOPURINOL |
8 | RASBURICASE | 389455 | 1% | 92% | 98 | Search RASBURICASE | Search RASBURICASE |
9 | XANTHINE OXIDASE | 273884 | 4% | 21% | 303 | Search XANTHINE+OXIDASE | Search XANTHINE+OXIDASE |
10 | HYPERURICAEMIA | 266855 | 1% | 74% | 83 | Search HYPERURICAEMIA | Search HYPERURICAEMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RICHETTE, P , DOHERTY, M , PASCUAL, E , BARSKOVA, V , BECCE, F , CASTANEDA-SANABRIA, J , COYFISH, M , GUILLO, S , JANSEN, TL , JANSSENS, H , ET AL (2017) 2016 UPDATED EULAR EVIDENCE-BASED RECOMMENDATIONS FOR THE MANAGEMENT OF GOUT.ANNALS OF THE RHEUMATIC DISEASES. VOL. 76. ISSUE 1. P. 29 -42 | 156 | 87% | 2 |
2 | SHEKELLE, PG , NEWBERRY, SJ , FITZGERALD, JD , MOTALA, A , O'HANLON, CE , TARIQ, A , OKUNOGBE, A , HAN, D , SHANMAN, R , (2017) MANAGEMENT OF GOUT: A SYSTEMATIC REVIEW IN SUPPORT OF AN AMERICAN COLLEGE OF PHYSICIANS CLINICAL PRACTICE GUIDELINE.ANNALS OF INTERNAL MEDICINE. VOL. 166. ISSUE 1. P. 37 -+ | 74 | 91% | 3 |
3 | KILTZ, U , ALTEN, R , FLECK, M , KRUGER, K , MANGER, B , MULLER-LADNER, U , NUSSLEIN, H , REUSS-BORST, M , SCHWARTING, A , SCHULZE-KOOPS, H , ET AL (2016) FULL VERSION OF THE S2E-GUIDELINES ON GOUTY ARTHRITIS: EVIDENCE-BASED GUIDELINES OF THE GERMAN SOCIETY OF RHEUMATOLOGY (DGRH).ZEITSCHRIFT FUR RHEUMATOLOGIE. VOL. 75. ISSUE . P. S11 -S60 | 155 | 97% | 1 |
4 | RICHETTE, P , BARDIN, T , (2010) GOUT.LANCET. VOL. 375. ISSUE 9711. P. 318 -328 | 109 | 87% | 237 |
5 | DALBETH, N , MERRIMAN, TR , STAMP, LK , (2016) GOUT.LANCET. VOL. 388. ISSUE 10055. P. 2039 -2052 | 125 | 91% | 2 |
6 | KANBAY, M , SEGAL, M , AFSAR, B , KANG, DH , RODRIGUEZ-ITURBE, B , JOHNSON, RJ , (2013) THE ROLE OF URIC ACID IN THE PATHOGENESIS OF HUMAN CARDIOVASCULAR DISEASE.HEART. VOL. 99. ISSUE 11. P. 759-766 | 107 | 87% | 84 |
7 | FEIG, DI , KANG, DH , JOHNSON, RJ , (2008) URIC ACID AND CARDIOVASCULAR RISK.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 359. ISSUE 17. P. 1811-1821 | 88 | 77% | 762 |
8 | SATTUI, SE , SINGH, JA , GAFFO, AL , (2014) COMORBIDITIES IN PATIENTS WITH CRYSTAL DISEASES AND HYPERURICEMIA.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 40. ISSUE 2. P. 251 -+ | 153 | 77% | 9 |
9 | BORGHI, C , ROSEI, EA , BARDIN, T , DAWSON, J , DOMINICZAK, A , KIELSTEIN, JT , MANOLIS, AJ , PEREZ-RUIZ, F , MANCIA, G , (2015) SERUM URIC ACID AND THE RISK OF CARDIOVASCULAR AND RENAL DISEASE.JOURNAL OF HYPERTENSION. VOL. 33. ISSUE 9. P. 1729 -1741 | 99 | 96% | 18 |
10 | DOUSDAMPANIS, P , TRIGKA, K , MUSSO, CG , FOURTOUNAS, C , (2014) HYPERURICEMIA AND CHRONIC KIDNEY DISEASE: AN ENIGMA YET TO BE SOLVED.RENAL FAILURE. VOL. 36. ISSUE 9. P. 1351 -1359 | 125 | 93% | 5 |
Classes with closest relation at Level 2 |